SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Chao Cheng, Sihua Wang, Ping Ye, Xiaofan Huang, Zheng Liu, Jie Wu, Yuan Sun, Aini Xie, Guohua Wang, Jiahong Xia, ‘Default’ generated neonatal regulatory T cells are hypomethylated at conserved non-coding sequence 2 and promote long-term cardiac allograft survival, Immunology, 2014, 143, 4
  2. 2
    Aldo J. Montano-Loza, Albert J. Czaja, Cell Mediators of Autoimmune Hepatitis and Their Therapeutic Implications, Digestive Diseases and Sciences, 2014,

    CrossRef

  3. 3
    Albert J Czaja, Current and prospective pharmacotherapy for autoimmune hepatitis, Expert Opinion on Pharmacotherapy, 2014, 15, 12, 1715

    CrossRef

  4. 4
    Muhammed Yüksel, Debby Laukens, Femke Heindryckx, Hans Van Vlierberghe, Anja Geerts, F. Susan Wong, Li Wen, Isabelle Colle, Hepatitis mouse models: from acute-to-chronic autoimmune hepatitis, International Journal of Experimental Pathology, 2014, 95, 5
  5. 5
    Richard Taubert, Matthias Hardtke-Wolenski, Fatih Noyan, Artur Wilms, Anna K. Baumann, Jerome Schlue, Sven Olek, Christine S. Falk, Michael P. Manns, Elmar Jaeckel, Intrahepatic regulatory T cells in autoimmune hepatitis are associated with treatment response and depleted with current therapies, Journal of Hepatology, 2014, 61, 5, 1106

    CrossRef

  6. 6
    Gabriel Marceau, Roland Yang, Pascal Lapierre, Kathie Béland, Fernando Alvarez, Low-dose anti-CD3 antibody induces remission of active autoimmune hepatitis in xenoimmunized mice, Liver International, 2014, 34, 10
  7. 7
    Anna Stelmaszczyk-Emmel, Regulatory T cells in children with allergy and asthma: It is time to act, Respiratory Physiology & Neurobiology, 2014,

    CrossRef

  8. 8
    A. J. Czaja, Review article: chemokines as orchestrators of autoimmune hepatitis and potential therapeutic targets, Alimentary Pharmacology & Therapeutics, 2014, 40, 3
  9. 9
    A. J. Czaja, Review article: permanent drug withdrawal is desirable and achievable for autoimmune hepatitis, Alimentary Pharmacology & Therapeutics, 2014, 39, 10
  10. 10
    A. J. Czaja, Review article: the prevention and reversal of hepatic fibrosis in autoimmune hepatitis, Alimentary Pharmacology & Therapeutics, 2014, 39, 4
  11. 11
    Hannah Jethwa, Antonella A. Adami, John Maher, Use of gene-modified regulatory T-cells to control autoimmune and alloimmune pathology: Is now the right time?, Clinical Immunology, 2014, 150, 1, 51

    CrossRef

  12. 12
    Zhenhai Yu, Yingying Ge, Lei Xie, Teng Zhang, Liangqian Huang, Xiaoping Zhao, Jianjun Liu, Gang Huang, Using a yeast two-hybrid system to identify FTCD as a new regulator for HIF-1α in HepG2 cells, Cellular Signalling, 2014, 26, 7, 1560

    CrossRef

  13. 13
    Diego Vergani, Ian R. Mackay, Giorgina Mieli-Vergani, The Autoimmune Diseases, 2014,

    CrossRef

  14. 14
    Ye Htun Oo, Shimon Sakaguchi, Regulatory T-cell directed therapies in liver diseases, Journal of Hepatology, 2013, 59, 5, 1127

    CrossRef

  15. 15
    K. Zachou, P. Muratori, G. K. Koukoulis, A. Granito, N. Gatselis, A. Fabbri, G. N. Dalekos, L. Muratori, Review article: autoimmune hepatitis – current management and challenges, Alimentary Pharmacology & Therapeutics, 2013, 38, 8